N-Acetylglucosamine

DB00141ApprovedInvestigationalNutraceuticalSmall molecule

The N-acetyl derivative of glucosamine.

Chemical structure of N-Acetylglucosamine
Mechanism
Curator reviewed
Primary indication
For the treatment and prevention of osteoarthritis, by itself or in combination with chondroitin sulfate.Curator reviewed
Formula / weight
C8H15NO6 · 221.2078 g/mol (avg)
Also known as
D-GlcNAc · N-Acetylchitosamine
Code names
NSC-400525 · NSC-524344

Resolves to

Structure
InChIKeyMBLBDJOUHNCFQT-LXGUWJNJSA-NSMILES[H]C(=O)[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@H](O)CO

What you can answer from here — as of September 12, 2026

6Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
11Marketed productsAcross 1 country and 8 labellers
Sign in
24+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with N-Acetylglucosamine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account